| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |